Technology ❯Biotechnology

Drug Development

GLP-1 Agonists Innovative Therapies High-Throughput Screening Computational Methods NaV1.8 Inhibitors MorphoSys Clinical Trials Immunotherapies Press Releases

AI-Designed Proteins Show Promise in Neutralizing Snake Venom Toxins

Xenon Pharmaceuticals to Showcase at BofA CNS Therapeutics Conference

Novartis Acquires MorphoSys for $2.9 Billion, Expanding Cancer Drug Portfolio

Vertex's Non-Opioid Painkiller Shows Promising Results in Mid-Stage Trial